BridgeMD
New treatment option for Anterior Cruciate Ligament Tear
Official title Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment.
ClinicalTrials.gov ID: NCT06353503
What this study is testing
- What it's testing
- A single armed multicenter study enrolling 20 patients using autologous bone marrow aspirate concentrate (which is done under local or general anesthesia to aspirate around 1-2 cc/kg body weight then concentration which is done by using centrifugation and special disposable kit) local injection of 4 cc per joint under ultrasonic guidance ,completely sterile field with local anesthesia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 55
You may be able to join if
- 1- Confirmed diagnosis of complete or partial ACL tear via clinical examination and imaging studies.
- 2\. Aged between 20 and 55 years, to encompass the typical age range of patients with sports-related ACL injuries.
You likely can't join if
- 1- Patients with a history of bleeding disorders, as this could complicate the aspiration and injection procedures.
- 2\. Individuals with a history of malignancy, due to the potential risks associated with growth factors present in BMAC.
- 3\. Critically ill patients or those with comorbidities
The study team makes the final eligibility decision.
Where it's taking place
- Baghdad, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baghdad, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.